SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Angela Chan1, Jennifer Tetzlaff2, Peter C Gøtzsche3, Douglas G. Altman4, Howard Mann5, Jesse A. Berlin6, Kay Dickersin7, A. Hrobjartsson3, Kenneth F Schulz8, Wendy R. Parulekar9, Karmela Krleža-Jerić10, Katharine Ker11, David Moher10,2
1Women’s College Research Institute at Women’s College
Hospital, Department of Medicine, University of Toronto, Toronto, Canada, M5G
1N8
2Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada
3Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
4Centre for Statistics in Medicine, University of Oxford, Oxford, UK
5Division of Medical Ethics and Humanities, University of Utah School of Medicine, Salt Lake City, USA
6Janssen Research and Development, Titusville, USA
7Center for Clinical Trials, Johns Hopkins Bloomberg
School of Public Health, Baltimore, USA
8Quantitative Sciences, FHI 360, Research Triangle
Park, USA
9NCIC Clinical Trials Group, Cancer Research Institute, Queen’s University, Kingston, Canada
10Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada
11Keenan Research Centre at the Li Ka Shing Knowledge
Institute of St Michael’s Hospital, Faculty of Medicine, University of Toronto,
Toronto, Canada
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
BMJ, The
Tập 346 Số jan08 15
e7586-e7586
Thông tin tác giả